Kengrexal 50 mg (Cangrelor (Cangrelor Tetrasodium) POWDER FOR SOLUTION) 50 MG

Kengrexal 50 mg is a powder for solution containing cangrelor tetrasodium, used for managing blood clotting during medical procedures. This intravenous medication is designed for controlled administration in clinical settings.

Strength

50 MG

Manufacturer / TM Owner

CHIESI FARMACEUTICI S.P.A.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Kengrexal 50 mg is primarily used to prevent blood clots during certain medical procedures. It works by inhibiting platelet aggregation, which is essential for maintaining blood flow during interventions like angioplasty. Patients may wonder, 'What is Kengrexal used for?'—it is typically administered to reduce the risk of clotting in specific cardiovascular scenarios.

Side Effects

Common effects of Kengrexal 50 mg may include bleeding or bruising at the injection site. Some individuals might experience dizziness or nausea. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

Kengrexal 50 mg should be handled with care, ensuring it is stored and prepared according to medical guidelines. It is crucial to follow proper administration protocols to minimize the risk of adverse reactions. Patients with a history of bleeding disorders should use this medication under close supervision.

Avoid Interactions

Kengrexal 50 mg may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Alcohol and certain supplements might also influence its effectiveness. Always inform healthcare providers about all medications being taken to avoid potential interactions.

References

Frequently Asked Questions

Kengrexal 50 mg is used to prevent blood clots during certain medical procedures, particularly those involving the cardiovascular system.

Kengrexal 50 mg is administered intravenously as a powder for solution, prepared and given by healthcare professionals.

Common side effects may include bleeding or bruising at the injection site, dizziness, and nausea.

Kengrexal 50 mg may interact with other blood-thinning medications, so it's important to consult a healthcare provider before combining treatments.

Individuals with a history of bleeding disorders or those on certain medications should use Kengrexal 50 mg with caution and under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.